Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anna S F Lok

Showing results (1-10 of 174) with videos related to

Pageof 18
Sort By:
Seminars in Liver Disease|March 5, 2003
Hepatitis B: progress in the last decadeAnna S F Lok
Clinical Liver Disease|April 18, 2019
New all-oral HCV therapies for genotype 1: A final good-bye to interferonAnna S F Lok
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|October 1, 2008
How to diagnose and treat hepatitis B virus antiviral drug resistance in the liver transplant settingAnna S F Lok
Journal of Hepatology|May 5, 2009
Evolution of nucleoside/tide analogues for hepatitis B: is the ideal drug here yet?Anna S F Lok
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|April 20, 2005
Liver transplantation for patients with lamivudine-resistant HBV: what is the optimal prophylactic strategy?Anna S F Lok
JAMA|November 14, 2012
Does antiviral therapy prevent recurrence of hepatitis B virus–related hepatocellular carcinoma after curative liver resection?Anna S F Lok
Hepatology (Baltimore, Md.)|July 3, 2010
Drug therapy: tenofovirAnna S F Lok
Gastroenterology|October 28, 2004
Prevention of hepatitis B virus-related hepatocellular carcinomaAnna S F Lok
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|October 4, 2002
Prevention of recurrent hepatitis B post-liver transplantationAnna S f Lok
Gut and Liver|March 27, 2024
Toward a Functional Cure for Hepatitis BAnna S F Lok
Pageof 18

Showing results (1-10 of 174) with videos related to

Sort By:
Pageof 18
Seminars in Liver Disease|March 5, 2003
Hepatitis B: progress in the last decadeAnna S F Lok
Clinical Liver Disease|April 18, 2019
New all-oral HCV therapies for genotype 1: A final good-bye to interferonAnna S F Lok
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|October 1, 2008
How to diagnose and treat hepatitis B virus antiviral drug resistance in the liver transplant settingAnna S F Lok
Journal of Hepatology|May 5, 2009
Evolution of nucleoside/tide analogues for hepatitis B: is the ideal drug here yet?Anna S F Lok
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|April 20, 2005
Liver transplantation for patients with lamivudine-resistant HBV: what is the optimal prophylactic strategy?Anna S F Lok
JAMA|November 14, 2012
Does antiviral therapy prevent recurrence of hepatitis B virus–related hepatocellular carcinoma after curative liver resection?Anna S F Lok
Hepatology (Baltimore, Md.)|July 3, 2010
Drug therapy: tenofovirAnna S F Lok
Gastroenterology|October 28, 2004
Prevention of hepatitis B virus-related hepatocellular carcinomaAnna S F Lok
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|October 4, 2002
Prevention of recurrent hepatitis B post-liver transplantationAnna S f Lok
Gut and Liver|March 27, 2024
Toward a Functional Cure for Hepatitis BAnna S F Lok
Pageof 18